Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-28 · accession 0001127602-25-007534 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-03 | 2025-02-28 | LXRX | MAIN ALAN J | EVP, Innov, Chem Sciences | F - Tax | $0.67 | -43.4K | 339.1K | -11% | -$29.1K |
| DM | 2025-03-03 | 2025-02-28 | LXRX | MAIN ALAN J | EVP, Innov, Chem Sciences | M - OptEx | — | +126.8K | 281.4K | +82% | — |
| DM | 2025-03-03 | 2025-02-28 | LXRX | MAIN ALAN J | EVP, Innov, Chem Sciences | M - OptEx | — | -126.8K | 32.9K | -79% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-28 | F | D | 43,434 | $0.67 | 339,104 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-28 | M | A | 68,243 | — | 382,538 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 3 | Common | Common Stock | 2025-02-28 | M | A | 32,904 | — | 314,295 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 4 | Common | Common Stock | 2025-02-28 | M | A | 25,667 | — | 281,391 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 5 | Derivative | Restricted Stock Units | 2025-02-28 | M | D | 68,243 | — | 136,487 | D | — · — to — | 68,243 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| 6 | Derivative | Restricted Stock Units | 2025-02-28 | M | D | 25,667 | — | 0 | D | — · — to — | 25,667 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| 7 | Derivative | Restricted Stock Units | 2025-02-28 | M | D | 32,904 | — | 32,903 | D | — · — to — | 32,904 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |